Skip to content

STERIS CORP

Delisted

CIK 815065fmd_0J1T7FBH81H6Y9NNK3F8471KSJManufacturing · Orthopedic, Prosthetic & Surgical Appliances & SuppliesTemplate: Standard

Coverage: Apr 01, 2008 to Sep 30, 2015, 27 periods

Latest annual · FY2015

Millions
Total revenues
1,850
Gross profit
774
Operating income
227
Net income
135
Free cash flow
161

Latest quarter · Q2 FY2016

Millions
Total revenues
490
Gross profit
209
Operating income
23
Net income
9
Free cash flow
22
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2012 to FY2015
+9.6%
Revenue, 5 yearsFY2010 to FY2015
+8.0%
Net income, 5 yearsFY2010 to FY2015
+1.0%

STERIS CORP financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2015FY2014ChangeSource
Revenue$1.9 billion$1.6 billion+14.1%10-K 2015-05-27 · proof
Gross profit$774.3 million$649.6 million+19.2%10-K 2015-05-27 · proof
Operating income$227.2 million$206.8 million+9.9%10-K 2015-05-27 · proof
Net income$135.1 million$129.4 million+4.3%10-K 2015-05-27 · proof
Cash from operating activities$246 million$209.6 million+17.4%10-K 2015-05-27 · proof
Free cash flow$160.8 million$123.3 million+30.4%10-K 2015-05-27 · proof
Total assets$2.1 billion$1.9 billion+11.1%10-Q 2015-08-07 · proof
Total liabilities$1 billion$845.9 million+21%10-Q 2015-08-07 · proof
Cash and cash equivalents$167.7 million$152.8 million+9.7%10-K 2015-05-27 · proof
What was STERIS CORP's revenue in fiscal 2015?
STERIS CORP reported revenue of $1.9 billion for fiscal 2015 (the year ended Mar 31, 2015), against $1.6 billion the year before (+14.1%). Source: the 10-K filed with the SEC on May 27, 2015. SEC
What was STERIS CORP's gross profit in fiscal 2015?
STERIS CORP reported gross profit of $774.3 million for fiscal 2015 (the year ended Mar 31, 2015), against $649.6 million the year before (+19.2%). Source: the 10-K filed with the SEC on May 27, 2015. SEC
What was STERIS CORP's operating income in fiscal 2015?
STERIS CORP reported operating income of $227.2 million for fiscal 2015 (the year ended Mar 31, 2015), against $206.8 million the year before (+9.9%). Source: the 10-K filed with the SEC on May 27, 2015. SEC
What was STERIS CORP's net income in fiscal 2015?
STERIS CORP reported net income of $135.1 million for fiscal 2015 (the year ended Mar 31, 2015), against $129.4 million the year before (+4.3%). Source: the 10-K filed with the SEC on May 27, 2015. SEC
What was STERIS CORP's cash from operating activities in fiscal 2015?
STERIS CORP reported cash from operating activities of $246 million for fiscal 2015 (the year ended Mar 31, 2015), against $209.6 million the year before (+17.4%). Source: the 10-K filed with the SEC on May 27, 2015. SEC
What was STERIS CORP's free cash flow in fiscal 2015?
STERIS CORP reported free cash flow of $160.8 million for fiscal 2015 (the year ended Mar 31, 2015), against $123.3 million the year before (+30.4%). Source: the 10-K filed with the SEC on May 27, 2015. SEC
What are STERIS CORP's total assets?
As of Mar 31, 2015, STERIS CORP reported total assets of $2.1 billion, against $1.9 billion a year earlier (+11.1%). Source: the 10-Q filed with the SEC on Aug 7, 2015 (restated). SEC
What are STERIS CORP's total liabilities?
As of Mar 31, 2015, STERIS CORP reported total liabilities of $1 billion, against $845.9 million a year earlier (+21%). Source: the 10-Q filed with the SEC on Aug 7, 2015 (restated). SEC
What are STERIS CORP's cash and cash equivalents?
As of Mar 31, 2015, STERIS CORP reported cash and cash equivalents of $167.7 million, against $152.8 million a year earlier (+9.7%). Source: the 10-K filed with the SEC on May 27, 2015. SEC

Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:815065&period_type=annual&limit=5"

Information only, not investment advice.